US 7576050
GLP-1 exendin-4 peptide analogs and uses thereof
granted A61KA61K38/00A61K38/2278
Quick answer
US patent 7576050 (GLP-1 exendin-4 peptide analogs and uses thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61K38/2278, A61K38/26, A61P